Specify the ashwagandha before asking for the gummy quote.
Sucotond USA coordinates custom ashwagandha gummy project review for U.S. brands. A comparable brief defines Withania somnifera, plant part, powder or extract basis, marker specification, amount per serving, gummy system, finished-product test plan, package and claim boundary.
This is a custom-project service, not a stocked formula or a promise of dose, withanolide level, shelf life, MOQ, timing, sensory outcome or finished-batch result.
Botanical Brief Controls“Ashwagandha extract” is not a complete material specification
NIH notes that commercial products can use root extracts or root-and-leaf extracts, and that root and leaf chemistry differ. FDA labeling guidance also requires the plant part for botanical dietary ingredients. The quote must therefore carry the same identity basis from supplier document to label draft.
| Field | What the buyer should define | Why it changes the quote or evidence |
|---|---|---|
| Botanical identity | Withania somnifera plus the common name used on the proposed label. | Prevents a marketing name from substituting for the exact dietary ingredient identity. |
| Plant part | Root, leaf, root-and-leaf, or another precisely documented basis. | Plant part affects material identity, label review and whether supplier evidence matches the proposed formula. |
| Material type | Whole powder or extract; extraction ratio or native basis where relevant; solvent and carrier declaration. | Two quotes with different extract or carrier bases are not the same formulation. |
| Marker specification | Which withanolide or total-withanolide definition, calculation basis, method, unit and acceptance range. | A percentage without its analytical and material basis cannot be translated safely into a finished serving. |
| Supplier / brand basis | Named supplier, branded material rights, or a written equivalent-material specification. | Documentation, minimums, substantiation rights and allowable label wording can differ by source. |
| Lot controls | Identity, marker assay, microbial, elemental-contaminant and other risk-based component specifications. | Component acceptance belongs upstream of finished-product release and must be linked to the actual lot. |
Lock nine inputs before comparing manufacturers
1. Botanical material
Species, plant part, powder/extract basis, supplier, carrier and component specification.
2. Serving declaration
Material amount per serving, gummies per serving, piece weight and separate marker basis.
3. Combination formula
Standalone ashwagandha or exact companion actives, each with its own amount and evidence basis.
4. Gummy system
Pectin or gelatin direction, sweeteners, flavor, color, coating, allergens and dietary exclusions.
5. Finished-product tests
Identity/marker strategy, microbiology, elemental contaminants and any project-specific panel.
6. Method and acceptance
Sample, analyte, preparation, method, laboratory, unit, criterion and disposition owner.
7. Package
Bottle or pouch, count, closure, liner, desiccant assumption, storage and distribution route.
8. Label and claims
Plant-part declaration, Supplement Facts basis, proposed structure/function language and review owner.
9. Commercial basis
Same formula, package, test/doc scope, delivery point, volume and timing assumptions for every quote.
If the project specifically combines a mineral and botanical, use the separate magnesium + ashwagandha gummy brief. It adds elemental-magnesium form, amount and mineral-method controls. Keep this page for standalone ashwagandha or a botanical-led formula.
Translate an approved botanical sample into a controlled batch
Component identity
Match the received lot, supplier documents, plant part and marker specification to the approved material basis.
Formula-space arithmetic
Convert the target material amount into per-piece load against the buyer-set piece weight before calling the concept feasible.
Dispersion and uniformity
Define the process and sampling evidence needed to evaluate distribution of the botanical material or selected marker.
Sensory system
Review botanical taste, color and odor together with acid, flavor, sweetener, coating and gummy-base decisions.
Method suitability
Do not assume a raw-material method automatically measures the selected analyte in the finished gummy matrix.
Package and time point
Tie any shelf-life statement to the actual formula, container-closure system, storage condition and evidence plan.
Every release claim should resolve to one identified lot or batch
Use the product specification checklist, sample-to-batch checklist and laboratory-report checklist to record those handoffs.
Use public guidance to sharpen the brief—not to promise a health outcome
NIH ODS: extracts and evidence are not interchangeable
NIH's health-professional fact sheet says root and leaf chemistry differ and notes that studies have used different extract types and doses. It also describes uncertainty about long-term safety and possible interactions. That supports exact material identification and conservative claim review; it does not validate a custom gummy or establish a universal dose.
FDA: plant part and serving basis belong on the label
FDA's dietary-supplement labeling guide says botanical dietary ingredients must identify the plant part and that Supplement Facts declares the amount per serving. That supports a species/plant-part/serving-first specification; it is not FDA approval of an ingredient, formula, claim or facility.
Choose the page that matches the formula—not the broadest keyword
Standalone or botanical-led ashwagandha
Use this page when ashwagandha identity, plant part, extract/marker basis and serving are the central specification decisions.
Scope Standalone AshwagandhaMagnesium + ashwagandha combination
Use the combination page when elemental magnesium form, mineral dose and mineral method must be reconciled with the botanical.
Open the Combination BriefAshwagandha gummy sourcing questions
Do you offer private label ashwagandha gummies?
Ashwagandha is open for custom-project review. The exact botanical material, serving, gummy system, testing, package, label, MOQ, timing and price require written project-specific confirmation.
Can I compare two quotes using only milligrams per serving?
No. Confirm species, plant part, powder or extract basis, carrier, marker definition and supplier basis. The same milligram number can describe materially different inputs.
Does a raw-material withanolide result release the finished gummy?
Not automatically. Component evidence and finished-product evidence address different samples. Define the analyte, matrix, method, unit, acceptance criterion and release responsibility for the finished batch.
What should an initial brief contain?
Send the target market, species and plant part, material specification or reference supplier, amount per serving, gummies per serving, companion actives, gummy base, package, test/document expectations, volume stage, delivery point and timing. Keep the first message non-confidential.
Request an ashwagandha gummy feasibility map
Send one shared specification basis that formulation, testing, packaging and commercial review can use.
Brooklyn, NY 11214